Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,431
+$19 QoQ
Shares Held
173
+64.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,230
of 1,408 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LOOMIS SAYLES & CO L P holds $224,982,288 across 8 Drug Manufacturers - Specialty & Generic names. ZTS ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
1,585,518 | $83,081,142 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,475,192 | $68,611,179 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
182,514 | $30,760,908 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
141,424 | $15,689,578 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
162,792 | $13,475,921 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
364,999 | $13,212,963 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
255 | $138,166 | |
| 8 | ZTS |
Zoetis Inc.
This page
|
173 | $12,431 |
All Filings in ZTS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,431 | 173 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,412 | 105 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $18,495 | 147 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $22,386 | 153 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $23,392 | 150 | Shares | Defined | 2025-08-13 | |
| 2024-09-30 | $61,349 | 314 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $53,741 | 310 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $51,270 | 303 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $63,553 | 322 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $74,115 | 426 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $49,252 | 286 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $55,757 | 335 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,068 | 96 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $15,867 | 107 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,204 | 71 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $15,464 | 82 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $31,967 | 131 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $38,828 | 200 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $27,394 | 147 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $22,047 | 140 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $26,314 | 159 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $28,609 | 173 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $27,408 | 200 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $24,832 | 211 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||